Cantor keeps USD 22.00 target for Omeros stock
Published on 10/20/2026 at 19:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and quarterly revenue
- Cantor Fitzgerald maintained its Overweight rating and USD 22.00 target on October 14, 2026.
- Second-quarter revenue reached USD 28.53 million versus USD 12.69 million estimates.
- Omeros stock costs EUR 14.78 at Lang & Schwarz on October 20, 2026 at 7:33 p.m. CEST.
- The next earnings report is expected on November 12, 2026.
Omeros Corporation (ISIN US6821431029) retains a USD 22.00 price target from Cantor Fitzgerald, while the latest quarter delivered USD 28.53 million in revenue against USD 12.69 million estimates. MarketBeat reported on October 14, 2026 that Cantor Fitzgerald reiterated its Overweight rating and kept the target at USD 22.00. Omeros stock was trading at EUR 14.78 at Lang & Schwarz on October 20, 2026 at 7:33 p.m. CEST.
What does the USD 22.00 target imply?
The target stood 32.37 percent above Omeros's USD 16.62 Nasdaq quote at 1:38 p.m. ET on October 20, 2026. Cantor's rating therefore left a wide gap between the research firm's valuation and the live US quotation.
Quarterly revenue beat estimates
Omeros reported USD 28.53 million in second-quarter 2026 revenue, compared with USD 12.69 million expected by analysts. The company also reported adjusted earnings per share of USD 0.02 for the quarter, versus a consensus loss of USD 0.27, according to MarketBeat. The figures cover the quarter ended June 30, 2026.
Range and next reporting date
Omeros had a 52-week Nasdaq range of USD 6.24 to USD 21.24 as of October 16, 2026. Its market capitalization was USD 1.2 billion and its price-to-earnings ratio was 12.66 on that date. MetaCap lists November 12, 2026 as the next expected earnings date.
Stock price and valuation
The euro quotation provides the German investor view, while the Nasdaq quotation keeps the analyst target in its original currency. The target, second-quarter revenue and November reporting date give investors three separate reference points for assessing Omeros.
Omeros market facts
- Company: Omeros Corporation
- ISIN: US6821431029
- Ticker: OMER
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 7:33 p.m. CEST): EUR 14.78
- Market capitalization: USD 1.2 billion (as of October 16, 2026)
- 52-week range: USD 6.24-21.24 (as of October 16, 2026)
- Sector / Industry: Healthcare / Biotechnology
- Next earnings date: November 12, 2026
The further course of trading is shown by the continuously updated real-time quote of Omeros stock.
Market context: Market report Nasdaq Composite.
